Actively Recruiting
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
Led by Peking University Shenzhen Hospital · Updated on 2025-06-12
50
Participants Needed
1
Research Sites
347 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
CONDITIONS
Official Title
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aerobic vaginitis diagnosed by the presence of vaginal discharge
- Vaginal pH greater than 4.5
- Donders score of 3 or higher
- Female participants aged between 18 and 55 years
You will not qualify if you...
- Having other types of vaginitis, cervical erosion, suspected gonorrhea, herpes simplex virus infection, or other vulvar diseases
- Received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission
- Pregnancy, breastfeeding, or planning to become pregnant
- Women with liver or kidney dysfunction, low immune function, diabetes, psychosis, or other serious diseases
- Allergy to the study drug or its ingredients
- Poor adherence or compliance with study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Shenzhen Hosptal
Shenzhen, Guangdong, China, 518036
Actively Recruiting
Research Team
P
Ping Liu, M.D.
CONTACT
Y
Yiheng Liang, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here